These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. A modified staging classification for cutaneous T-cell lymphoma. Kashani-Sabet M, McMillan A, Zackheim HS. J Am Acad Dermatol; 2001 Nov; 45(5):700-6. PubMed ID: 11606919 [Abstract] [Full Text] [Related]
9. Cutaneous T cell lymphoma: the helping hand of dendritic cells. Edelson RL. Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563 [Abstract] [Full Text] [Related]
10. High-dose recombinant interleukin-2 in advanced cutaneous T-cell lymphoma. Marolleau JP, Baccard M, Flageul B, Rybojad M, Laroche L, Vérola O, Brandely M, Morel P, Gisselbrecht C. Arch Dermatol; 1995 May; 131(5):574-9. PubMed ID: 7741545 [Abstract] [Full Text] [Related]
11. Controversies in the management of the cutaneous T cell lymphomas. Zic JA. Dermatol Ther; 2009 May; 22(5):407-17. PubMed ID: 19845718 [Abstract] [Full Text] [Related]
19. Applying the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome in primary cutaneous marginal zone lymphoma. Gerami P, Wickless SC, Rosen S, Kuzel TM, Ciurea A, Havey J, Guitart J. J Am Acad Dermatol; 2008 Aug; 59(2):245-54. PubMed ID: 18486274 [Abstract] [Full Text] [Related]